X4 Pharmaceuticals Enters Up to $150 Million Term Loan Facility
MT newswire2026/10/08 11:5407:54 AM EDT, 10/08/2026 (MT Newswires) -- X4 Pharmaceuticals (XFOR) said Thursday it has entered into a senior secured term loan facility of up to $150 million with K2 HealthVentures. The facility includes $80 million at closing, and an additional $70 million that X4 may access subject to K2 HealthVentures' approval and other conditions, the company said. X4 said it used the initial proceeds to repay its previous loan, including $75 million of principal and related fees. The new facility has a 48-month maturity and a longer interest-only period than the previous loan, X4 said.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
